Description

Bilypsa Tablet is a medicine that contains saroglitazar as its active ingredient. Saroglitazar is a dual peroxisome proliferator-activated receptor (PPAR) agonist that works by reducing lipid and glucose levels in the body. It is prescribed for the treatment of dyslipidemia and type 2 diabetes mellitus. Bilypsa Tablet is effective in controlling elevated levels of triglycerides, total cholesterol, low-density lipoprotein (LDL) cholesterol, and increasing high-density lipoprotein (HDL) cholesterol. It also helps in improving insulin sensitivity and glycemic control in patients with diabetes. This medication is commonly used as an adjunct to a proper diet and regular exercise to manage lipid disorders and type 2 diabetes. It further aids in reducing the risk of cardiovascular events in patients with atherosclerosis.

Additional information